First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383

NCT05429723 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Cough

Interventions

DRUG: HS-10383
DRUG: HS-10383 Placebo

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.